Gilead Sciences (GILD) Leases (2019 - 2024)
Historic Leases for Gilead Sciences (GILD) over the last 9 years, with Q4 2024 value amounting to $515.0 million.
- Gilead Sciences' Leases fell 1135.97% to $515.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $515.0 million, marking a year-over-year decrease of 1135.97%. This contributed to the annual value of $515.0 million for FY2024, which is 1135.97% down from last year.
- As of Q4 2024, Gilead Sciences' Leases stood at $515.0 million, which was down 1135.97% from $581.0 million recorded in Q4 2023.
- In the past 5 years, Gilead Sciences' Leases registered a high of $646.0 million during Q4 2020, and its lowest value of $505.0 million during Q4 2022.
- In the last 5 years, Gilead Sciences' Leases had a median value of $542.0 million in 2021 and averaged $557.8 million.
- Its Leases has fluctuated over the past 5 years, first tumbled by 1609.91% in 2021, then soared by 1504.95% in 2023.
- Gilead Sciences' Leases (Quarter) stood at $646.0 million in 2020, then decreased by 16.1% to $542.0 million in 2021, then dropped by 6.83% to $505.0 million in 2022, then grew by 15.05% to $581.0 million in 2023, then fell by 11.36% to $515.0 million in 2024.
- Its last three reported values are $515.0 million in Q4 2024, $581.0 million for Q4 2023, and $505.0 million during Q4 2022.